LINC01101, A Long Intergenic Non-protein Coding RNA Molecule as A Potential Drug Target Or Biomarker

Target Name: LINC01101

NCBI ID: G84931

LINC01101

Other Name(s): long intergenic non-protein coding RNA 1101 | Long intergenic non-protein coding RNA 1101

LINC01101, A Long Intergenic Non-protein Coding RNA Molecule as A Potential Drug Target Or Biomarker

LINC01101 is a long intergenic non-protein coding RNA (lncRNA) molecule that has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is found in various tissues and cells in the human body.

LINC01101 is characterized by its unique structure and sequence. It is composed of 241 nucleotides and has a molecular weight of 29.9 kDa. The RNA molecule is primarily composed of a single transcript, but there are some potential duplications in the primary transcript.

The function of LINC01101 is not yet fully understood, but research has shown that it is involved in various cellular processes. It has been shown to be involved in cell adhesion, migration, and invasion.

One of the key features of LINC01101 is its ability to interact with other molecules. It has been shown to interact with various proteins, including the protein known as SMAD4. This interaction between LINC01101 and SMAD4 could be a potential target for drugs that are designed to modulate the activity of SMAD4.

Another potential mechanism by which LINC01101 could be targeted by drugs is its role in cell signaling pathways. It has been shown to be involved in various signaling pathways, including the TGF-β pathway. This suggests that LINC01101 could be a potential drug target for molecules that are designed to modulate TGF-β signaling.

In addition to its potential role in cellular signaling pathways, LINC01101 has also been shown to be involved in the regulation of gene expression. It has been shown to play a role in the regulation of various gene expressions, including the regulation of cell adhesion and the development of cancer.

Given its unique structure and function, LINC01101 is an attractive candidate for drug development as a potential drug target or biomarker. Further research is needed to fully understand its role in cellular processes and its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1101

The "LINC01101 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01101 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets